Videos
Free videos
Talks that open on YouTube. Nothing plays until the link is opened.
Myeloma
8 videos
Oncology Data Advisor · 2026-03-31 · 18:30
MRD in Multiple Myeloma: FDA Draft Guidance Explained
myeloma
International Academy for Clinical Hematology (IACH) · 2026-10-07 · 28:04
Multiple Myeloma Masterclass Series - MRD-guided treatment decisions: from bench to bedside
myeloma
OncoDaily TV · 2026-06-01 · 3:46
How Long-Term MRD Negativity Redefines Prognosis in Myeloma: Dr. Mattia D'Agostino
myeloma
Mattia D'Agostino
VJHemOnc · 2025-02-10 · 1:58
The use of MRD to guide maintenance therapy discontinuation in patients with multiple myeloma
myeloma
VJHemOnc · 2025-10-01 · 1:13
The role of MRD in guiding maintenance treatment decisions in multiple myeloma
myeloma
MVR Cancer Centre & Research Institute · 2025-06-06 · 26:39
Minimal Residual Disease (MRD) in Multiple Myeloma by Dr. Ann Thomas
myeloma
Ann Thomas
Leukemia
5 videos
UT MD Anderson Cancer Center · 2025-06-10 · 29:33
Tracking leukemia with minimal residual disease (MRD)
leukemia
VJHemOnc · 2018-12-02 · 1:28
Flow cytometry vs. NGS testing for determining MRD negativity in patients with ALL
ALL
Hematologic
2 videos
Colorectal / GI
10 videos
OncologyTube · 2025-01-29 · 13:44
The Role of Circulating Tumor DNA (ctDNA) in Colorectal Cancer Management - Pashtoon Kasi MD, MS
colorectal
Pashtoon Kasi
VJOncology · 2026-06-23 · 2:39
Using ctDNA to guide adjuvant chemotherapy for colon cancer: insights from the CIRCULATE trial
colorectal
VJOncology · 2025-07-24 · 2:07
What is the future role of ctDNA as a biomarker in colorectal cancer?
colorectal
VJOncology · 2026-06-03 · 0:50
Using ctDNA to inform treatment strategies in colorectal cancer
colorectal
VJOncology · 2025-11-13 · 1:14
ctDNA clearance and outcomes in the INTERCEPT colorectal cancer study
colorectal
HMP Global · 2017-04-17 · 12:01
Debate: Is circulating tumor DNA ready to guide adjuvant therapy in colon cancer? - Yes
colorectal
ecancer · 2022-06-15 · 5:33
Circulating tumour DNA analysis can help identify the need for CT in stage II colon cancer
colorectal
ecancer · 2026-02-05 · 5:11
Circulating tumour DNA a useful marker in CRC treatment efficacy, but only alongside others
colorectal
Bladder / urothelial
2 videos
Personalis, Inc. · 2026-03-31 · 3:07
ASCO GU 2026: Bladder Cancer
bladder / urothelial carcinoma
Alan Tan, Mehmet Murat Zerey
Preliminary real-world results of ultrasensitive whole-genome ctDNA clearance as a biomarker with enfortumab vedotin plus pembrolizumab
Posted by Personalis, Inc.
BackTable Tumor Board · 2026-01-27 · 57:34
Urothelial Carcinoma: Understanding CTDNA & Precision Medicine w/ Drs. Nizam & McGregor | BackTable Tumor Board Ep. 45
urothelial carcinoma / MIBC
Alan Tan, Amanda Nizam, Brad McGregor
ctDNA in assessing recurrence risk and tailoring perioperative therapy in urothelial carcinoma
Kidney
2 videos
Personalis, Inc. · 2026-04-01 · 5:07
ASCO GU 2026: Kidney Cancer (RCC)
kidney (high-risk localized RCC)
Paulo Siqueira Amaral, Alan Tan
Ultrasensitive whole-genome ctDNA to evaluate recurrence risk after nephrectomy; detections ahead of radiographic recurrence
Posted by Personalis, Inc.
Genitourinary
1 videos
BackTable Tumor Board · 2026-08-11 · 28:17
GU Oncology: ASCO Highlights and Impacts on Practice w/ Dr. Alan Tan | BackTable Tumor Board Ep. 76
GU (includes RCC ctDNA segment)
Alan Tan, Katy Beckermann